Drug Shortage Report for ANGELIQ
| Report ID | 167449 |
| Drug Identification Number | 02268825 |
| Brand name | ANGELIQ |
| Common or Proper name | Drospirenone /Estradiol-17ß |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESTRADIOL DROSPIRENONE |
| Strength(s) | 1.0MG 1.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28's |
| ATC code | G03FA |
| ATC description | PROGESTOGENS AND ESTROGENS IN COMBINATION |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-08-22 |
| Actual start date | 2022-08-24 |
| Estimated end date | 2022-08-30 |
| Actual end date | 2022-08-26 |
| Shortage status | Resolved |
| Updated date | 2022-08-29 |
| Company comments | Supply constraints |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-08-19 | English | Compare |
| v2 | 2022-08-19 | French | Compare |
| v3 | 2022-08-23 | English | Compare |
| v4 | 2022-08-25 | English | Compare |
| v5 | 2022-08-25 | French | Compare |
| v6 | 2022-08-29 | English | Compare |
| v7 | 2022-08-29 | French | Compare |
Showing 1 to 7 of 7